Brief: Glenmark Pharmaceuticals Receives MHRA Approval To Market Winlevi In UK
10/02/2025 06:51
Feb 10 (Reuters) - Glenmark Pharmaceuticals Ltd
GLEN.NS :
* RECEIVES MHRA APPROVAL TO MARKET WINLEVI IN UK
* WINLEVI APPROVED FOR TREATMENT OF ACNE VULGARIS IN
PATIENTS AGED
12+
Source text: ID:nBSE85XZy7
Further company coverage: GLEN.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Glenmark Pharmaceuticals
See all newsBrief: Glenmark Pharma Says Unit Launches Ryaltris Nasal Spray In Brazil For Allergic Rhinitis
Brief: Glenmark Pharma US Unit Launches Calcium Gluconate Injection USP In Multiple Vial Sizes
India's Glenmark Pharma gains most in three weeks on US approval for Flonase nasal spray
Brief: Glenmark Pharma Gets U.S. FDA Approval For Fluticasone Propionate Nasal Spray 0.05 Mg/Spray
India's Glenmark Pharmaceuticals falls as brokerage flags softer-than-expected quarter